Brompton Funds Limited · TSX
| Assets under management | $66.42M |
|---|---|
| Expense ratio | — |
| Category | — |
| Dividend yield | — |
| NAV | $7.40 |
| Fund family | Brompton Funds Limited |
| Exchange | TSX |
The largest positions Brompton Global Healthcare Income & Growth ETF reports, by weight.
| Holding | Name | Weight |
|---|---|---|
| JNJ | Johnson & Johnson | 5.62% |
| NVS | Novartis AG ADR | 5.43% |
| GILD | Gilead Sciences Inc | 5.41% |
| CAH | Cardinal Health Inc | 5.35% |
| BMY | Bristol-Myers Squibb Co | 5.26% |
| LLY | Eli Lilly and Co | 5.24% |
| VRTX | Vertex Pharmaceuticals Inc | 5.02% |
| MRK | Merck & Co Inc | 4.97% |
| UNH | UnitedHealth Group Inc | 4.56% |
| MCK | McKesson Corp | 4.51% |